Trypanosoma cruzi STIB980: A TcI Strain for Drug Discovery and Reverse Genetics
Trypanosoma cruzi STIB980: A TcI Strain for Drug Discovery and Reverse Genetics
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Since the first published genome sequence of Trypanosoma cruzi in 2005, there have been tremendous technological advances in genomics, reverse genetics, and assay development for this elusive pathogen. However, there is still an unmet need for new and better drugs to treat Chagas disease. Here, we introduce a T. cruzi assay strain that is useful fo...
Alternative Titles
Full title
Trypanosoma cruzi STIB980: A TcI Strain for Drug Discovery and Reverse Genetics
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_87d78897c39f47dba42170d34ad011b9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87d78897c39f47dba42170d34ad011b9
Other Identifiers
ISSN
2076-0817
E-ISSN
2076-0817
DOI
10.3390/pathogens12101217
